JP2025161809A5 - - Google Patents

Info

Publication number
JP2025161809A5
JP2025161809A5 JP2025109210A JP2025109210A JP2025161809A5 JP 2025161809 A5 JP2025161809 A5 JP 2025161809A5 JP 2025109210 A JP2025109210 A JP 2025109210A JP 2025109210 A JP2025109210 A JP 2025109210A JP 2025161809 A5 JP2025161809 A5 JP 2025161809A5
Authority
JP
Japan
Prior art keywords
nucleic acid
target nucleic
crispr
cell
associated protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025109210A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025161809A (ja
Filing date
Publication date
Priority claimed from PCT/US2020/049923 external-priority patent/WO2021050534A1/en
Application filed filed Critical
Publication of JP2025161809A publication Critical patent/JP2025161809A/ja
Publication of JP2025161809A5 publication Critical patent/JP2025161809A5/ja
Pending legal-status Critical Current

Links

JP2025109210A 2019-09-09 2025-06-27 新規crispr dnaターゲティング酵素及びシステム Pending JP2025161809A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962897859P 2019-09-09 2019-09-09
US62/897,859 2019-09-09
PCT/US2020/049923 WO2021050534A1 (en) 2019-09-09 2020-09-09 Novel crispr dna targeting enzymes and systems
JP2022515511A JP7705382B2 (ja) 2019-09-09 2020-09-09 新規crispr dnaターゲティング酵素及びシステム

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022515511A Division JP7705382B2 (ja) 2019-09-09 2020-09-09 新規crispr dnaターゲティング酵素及びシステム

Publications (2)

Publication Number Publication Date
JP2025161809A JP2025161809A (ja) 2025-10-24
JP2025161809A5 true JP2025161809A5 (cg-RX-API-DMAC10.html) 2025-11-20

Family

ID=74866391

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022515511A Active JP7705382B2 (ja) 2019-09-09 2020-09-09 新規crispr dnaターゲティング酵素及びシステム
JP2025109210A Pending JP2025161809A (ja) 2019-09-09 2025-06-27 新規crispr dnaターゲティング酵素及びシステム

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022515511A Active JP7705382B2 (ja) 2019-09-09 2020-09-09 新規crispr dnaターゲティング酵素及びシステム

Country Status (11)

Country Link
US (5) US12460190B2 (cg-RX-API-DMAC10.html)
EP (1) EP4028047A4 (cg-RX-API-DMAC10.html)
JP (2) JP7705382B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220054434A (cg-RX-API-DMAC10.html)
CN (1) CN114340657A (cg-RX-API-DMAC10.html)
AU (1) AU2020347147A1 (cg-RX-API-DMAC10.html)
CA (1) CA3150454A1 (cg-RX-API-DMAC10.html)
IL (1) IL291095A (cg-RX-API-DMAC10.html)
MX (1) MX2022002872A (cg-RX-API-DMAC10.html)
WO (1) WO2021050534A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202202628B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
US12460190B2 (en) * 2019-09-09 2025-11-04 Arbor Biotechnologies, Inc. CRISPR DNA targeting enzymes and systems
WO2021133829A1 (en) 2019-12-23 2021-07-01 The Regents Of The University Of California Crispr-cas effector polypeptides and methods of use thereof
CA3211223A1 (en) * 2021-03-09 2022-09-15 Shaorong Chong Compositions comprising a variant polypeptide and uses thereof
CN117043326A (zh) * 2021-03-09 2023-11-10 阿伯生物技术公司 包含变体多肽的组合物及其用途
AU2022234760A1 (en) 2021-03-09 2023-09-14 Arbor Biotechnologies, Inc. Compositions comprising a variant polypeptide and uses thereof
AU2022284804A1 (en) 2021-06-01 2023-12-07 Arbor Biotechnologies, Inc. Gene editing systems comprising a crispr nuclease and uses thereof
WO2023250384A2 (en) * 2022-06-22 2023-12-28 The Regents Of The University Of California Crispr-cas effector polypeptides and methods of use thereof
WO2024020557A1 (en) * 2022-07-22 2024-01-25 Arbor Biotechnologies, Inc. Compositions comprising a variant nuclease and uses thereof
US20240035010A1 (en) * 2022-07-22 2024-02-01 Arbor Biotechnologies, Inc. Compositions comprising a variant polypeptide and uses thereof
CN121896200A (zh) * 2022-12-06 2026-04-21 山东舜丰生物科技有限公司 Crispr酶和系统及应用
US20260232844A1 (en) 2023-02-15 2026-08-13 Arbor Biotechnologies, Inc. Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript
WO2025006563A1 (en) 2023-06-26 2025-01-02 Arbor Biotechnologies, Inc. Gene editing systems targeting pcsk9 and uses thereof
WO2025171210A1 (en) 2024-02-09 2025-08-14 Arbor Biotechnologies, Inc. Compositions and methods for gene editing via homology-mediated end joining
WO2025212120A1 (en) 2024-04-05 2025-10-09 Arbor Biotechnologies, Inc. Chemical modifications of guide rnas for crispr nucleases
WO2026015829A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Small reverse transcriptases and gene editing systems comprising such
WO2026015832A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such
WO2026139426A1 (en) * 2024-12-26 2026-07-02 UCB Biopharma SRL Novel rna-guided nucleases and nucleic acid targeting systems comprising such rna-guided nucleases

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US20040052799A1 (en) 1996-11-15 2004-03-18 Astra Aktiebolag Nucleic acid and amino acid sequences relating to Helicobacter pylori for diagnostics and therapeutics
US20040216190A1 (en) * 2003-04-28 2004-10-28 Kovalic David K. Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
EP2397490B1 (en) 2004-07-16 2013-09-04 THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Vaccine constructs and combinations of vaccines designed to improve the breadth of the immune response to diverse strains and clades of HIV
US8703147B2 (en) * 2007-11-05 2014-04-22 The Walter And Eliza Hall Institute Of Medical Research Methods and compositions for treating and preventing malaria (2)
WO2011119484A1 (en) 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
WO2013082500A2 (en) 2011-12-02 2013-06-06 Rhode Island Hospital Vaccine for falciparum malaria
KR102955556B1 (ko) 2012-12-12 2026-04-22 더 브로드 인스티튜트, 인코퍼레이티드 서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물
WO2016094874A1 (en) 2014-12-12 2016-06-16 The Broad Institute Inc. Escorted and functionalized guides for crispr-cas systems
EP3230452B1 (en) 2014-12-12 2025-06-11 The Broad Institute, Inc. Dead guides for crispr transcription factors
US20180187190A1 (en) * 2015-06-12 2018-07-05 Erasmus University Medical Center Rotterdam New crispr assays
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
CA3012631A1 (en) * 2015-06-18 2016-12-22 The Broad Institute Inc. Novel crispr enzymes and systems
CN116814590A (zh) * 2015-10-22 2023-09-29 布罗德研究所有限公司 Vi-b型crispr酶和系统
CA3026110A1 (en) 2016-04-19 2017-11-02 The Broad Institute, Inc. Novel crispr enzymes and systems
US10125246B2 (en) * 2016-06-24 2018-11-13 King Fahd University Of Petroleum And Minerals Low density polyethylene (LDPE)-asphaltene composition and method of preparation
EP3526326A4 (en) 2016-10-12 2020-07-29 The Regents of The University of Colorado, A Body Corporate NEW MODIFIED AND CHEMERICAL NUCLEASES
US10392616B2 (en) 2017-06-30 2019-08-27 Arbor Biotechnologies, Inc. CRISPR RNA targeting enzymes and systems and uses thereof
US12460190B2 (en) 2019-09-09 2025-11-04 Arbor Biotechnologies, Inc. CRISPR DNA targeting enzymes and systems

Similar Documents

Publication Publication Date Title
JP2022547524A5 (cg-RX-API-DMAC10.html)
JP2022546701A5 (cg-RX-API-DMAC10.html)
CN113373130A (zh) Cas12蛋白、含有Cas12蛋白的基因编辑系统及应用
CN109136248B (zh) 多靶点编辑载体及其构建方法和应用
JP2019162140A (ja) Crisprハイブリッドdna/rnaポリヌクレオチドおよび使用方法
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
AU2020356441B2 (en) A nucleic acid delivery vector comprising a circular single stranded polynucleotide
WO2018033110A1 (zh) 一种基因点突变修复的方法
JP2024524514A5 (cg-RX-API-DMAC10.html)
JP2022540153A5 (cg-RX-API-DMAC10.html)
JP2022546594A5 (cg-RX-API-DMAC10.html)
JP2022538789A5 (cg-RX-API-DMAC10.html)
CN116694603A (zh) 新型的Cas蛋白、Crispr-Cas系统及其在基因编辑领域中的用途
WO2023206872A1 (zh) 一种工程优化的核酸酶、向导rna、编辑系统和应用
WO2023165613A1 (zh) 5'→3'核酸外切酶在基因编辑系统中的用途和基因编辑系统及其编辑方法
WO2023169482A1 (en) Modified crispr-based gene editing system and methods of use
CN112592923A (zh) Ires序列、ires序列的应用和多顺反子表达载体
JP2022551931A (ja) 改変エンドヌクレアーゼおよび関連方法
US20220364122A1 (en) Bacterial platform for delivery of gene-editing systems to eukaryotic cells
CN117987464A (zh) 一种供体构建体、用于修饰细胞基因组的组合物及修饰细胞基因组的方法
CN120051576A (zh) 生产合成环状核酸的无细胞方法
CN116004716A (zh) 一种复制型dCas9-FokI系统进行高效基因编辑的方法
JP2024513967A (ja) 非ウイルス相同性媒介末端結合
CA3155960C (en) A nucleic acid delivery vector comprising a circular single stranded polynucleotide
EP4686758A1 (en) Nucleic acid for nuclear translocation